EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells

Mark F Bird, Christopher P Hebbes, Anushuya Tamang, Jonathon Mark Willets iD, Jonathan P Thompson iD, Remo Guerrini iD, Girolamo Calo iD, David G Lambert iD

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16088 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Mark F Bird and 7 co-authors. Institution: Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester, UK. Major MEDLINE topics: Receptors, Opioid, Sepsis. Cited 3 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY 4.0). Funded by: Biotechnology and Biological Sciences Research Council.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background and Purpose In animal models of sepsis, increased activation of the Nociceptin/Orphanin FQ (N/OFQ) receptor NOP is associated with mortality and NOP antagonists improved survival. We have explored the role of the N/OFQ‐NOP system in freshly isolated volunteer human B‐ and T‐cells incubated with lipopolysaccharide (LPS) and peptidoglycan G (PepG) as a model of in vitro sepsis. Experimental Approach B‐ and T‐cell NOP expression was measured using the NOP fluorescent probe N/OFQ ATTO594 , N/OFQ content was measured using immunofluorescence, N/OFQ release was tracked using a CHO hNOPGαiq5 biosensor assay and NOP function was measured using transwell migration and cytokine/chemokine release using a 25‐plex assay format. Cells were challenged with LPS/PepG. Key Results CD19‐positive B‐cells bound N/OFQ ATTO594 ; they also contain N/OFQ. Stimulation with CXCL13/IL‐4 increased N/OFQ release. N/OFQ trended to reduced migration to CXCL13/IL‐4. Surface NOP expression was unaffected by LPS/PepG, but this treatment increased GM‐CSF release in an N/OFQ sensitive manner. CD3‐positive T‐cells did not bind N/OFQ ATTO594 ; they did contain N/OFQ. Stimulation with CXCL12/IL‐6 increased N/OFQ release. When incubated with LPS/PepG, NOP surface expression was induced leading to N/OFQ ATTO594 binding. In LPS/PepG‐treated cells, N/OFQ reduced migration to CXCL12/IL‐6. LPS/PepG increased GM‐CSF release in an N/OFQ sensitive manner. Conclusions and Implications We suggest both a constitutive and sepsis‐inducible N/OFQ‐NOP receptor autocrine regulation of B‐ and T‐cell function, respectively. These NOP receptors variably inhibit migration and reduce GM‐CSF release. These data provide mechanistic insights to the detrimental role for increased N/OFQ signalling in sepsis and suggest a potential role for NOP antagonists as treatments.

Subjects

MeSH terms (MEDLINE)

Receptors, OpioidSepsisAnimalsHumansNociceptin ReceptorGranulocyte-Macrophage Colony-Stimulating FactorLipopolysaccharidesInterleukin-4Interleukin-6Opioid PeptidesNociceptin

Author keywords

B-cellsNOP receptorNociceptin/Orphanin FQT-cellsbiosensorconfocal microscopysepsis

Substances

Receptors, OpioidNociceptin ReceptorGranulocyte-Macrophage Colony-Stimulating FactorLipopolysaccharidesInterleukin-4Interleukin-6Opioid PeptidesNociceptin

Authors and institutions

  • Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester, UK.
  • Cellomatics Biosciences Ltd, Nottingham, UK.
  • Molecular and Cell Biology, University of Leicester, Leicester, UK.
  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy.

ORCID profiles: Jonathon Mark Willets, Jonathan P Thompson, Remo Guerrini, Girolamo Calo, David G Lambert

Funding

  • Biotechnology and Biological Sciences Research Council

Cite

APA

Bird, M. F., Hebbes, C. P., Tamang, A., Willets, J. M., Thompson, J. P., Guerrini, R., Calo, G., & Lambert, D. G. (2023). In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.16088

Vancouver

Bird MF, Hebbes CP, Tamang A, Willets JM, Thompson JP, Guerrini R, et al. In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells. British Journal of Pharmacology. 2023. doi:10.1111/bph.16088

BibTeX
@article{Bird2023,
  author = {Bird, Mark F and Hebbes, Christopher P and Tamang, Anushuya and Willets, Jonathon Mark and Thompson, Jonathan P and Guerrini, Remo and Calo, Girolamo and Lambert, David G},
  title = {In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16088}
}
Start for free →